Pulse Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLSE and other ETFs, options, and stocks.

About PLSE

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. 

CEO
Paul A. LaViolette
CEOPaul A. LaViolette
Employees
116
Employees116
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2014
Founded2014
Employees
116
Employees116

PLSE Key Statistics

Market cap
3.36B
Market cap3.36B
Price-Earnings ratio
-39.44
Price-Earnings ratio-39.44
Dividend yield
—
Dividend yield—
Average volume
424.73K
Average volume424.73K
High today
$48.97
High today$48.97
Low today
$44.80
Low today$44.80
Open price
$47.60
Open price$47.60
Volume
440.28K
Volume440.28K
52 Week high
$58.90
52 Week high$58.90
52 Week low
$12.56
52 Week low$12.56

Stock Snapshot

As of today, Pulse Biosciences(PLSE) shares are valued at $45.63. The company's market cap stands at 3.36B, with a P/E ratio of -39.44.

As of 2026-10-15, Pulse Biosciences(PLSE) stock has fluctuated between $44.80 and $48.97. The current price stands at $45.63, placing the stock +1.9% above today's low and -6.8% off the high.

The Pulse Biosciences(PLSE)'s current trading volume is 440.28K, compared to an average daily volume of 424.73K.

During the past year, Pulse Biosciences(PLSE) stock moved between $12.56 at its lowest and $58.90 at its peak.

During the past year, Pulse Biosciences(PLSE) stock moved between $12.56 at its lowest and $58.90 at its peak.

PLSE News

TipRanks 20h
Pulse Biosciences partners Clayman Thyroid Center on nsPFA

Pulse Biosciences ( (PLSE) ) has shared an announcement. On October 14, 2026, Pulse Biosciences announced a commercial and clinical partnership with the Clayma...

Investing.com 2d
Oppenheimer raises Pulse Biosciences price target on competitor issues - Investing.com

...

Oppenheimer raises Pulse Biosciences price target on competitor issues - Investing.com
Simply Wall St 6d
Pulse Biosciences Could Be 7% Undervalued On NANOPULSE AF Enrollment Milestone

Advertisement Why the NANOPULSE-AF enrollment milestone matters for Pulse Biosciences Pulse Biosciences (PLSE) has hit full enrollment in its pivotal NANOPULS...

Pulse Biosciences Could Be 7% Undervalued On NANOPULSE AF Enrollment Milestone

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own PLSE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.